Compare · APT vs STE
APT vs STE
Side-by-side comparison of Alpha Pro Tech Ltd. (APT) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APT and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $21.87B, about 374.7x APT ($58.4M).
- APT has been more active in the news (14 items in the past 4 weeks vs 4 for STE).
- STE has more recent analyst coverage (17 ratings vs 0 for APT).
- Company
- Alpha Pro Tech Ltd.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $58.4M
- $21.87B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- AMEX
- NYSE
- IPO
- 2000
- News (4w)
- 14
- 4
- Recent ratings
- 0
- 17
Alpha Pro Tech Ltd.
Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through two segments, Disposable Protective Apparel and Building Supply. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap, synthetic roof underlayment, and other woven materials. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites; and pharmaceutical markets. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest APT
- Director Ritota John was granted 5,860 shares, increasing direct ownership by 14% to 47,215 units (SEC Form 4)
- Director Shaw Benjamin A was granted 5,860 shares, increasing direct ownership by 57% to 16,215 units (SEC Form 4)
- Director Buchan James was granted 5,860 shares, increasing direct ownership by 104% to 11,475 units (SEC Form 4)
- Director Garcia David R was granted 5,860 shares, increasing direct ownership by 30% to 25,628 units (SEC Form 4)
- Director Montgomery Charles D covered exercise/tax liability with 13,057 shares, sold $110,593 worth of shares (21,943 units at $5.04) and was granted 33,000 shares, decreasing direct ownership by 3% to 58,281 units (SEC Form 4)
- Amendment: Director Montgomery Charles D sold $152,319 worth of shares (23,886 units at $6.38), decreasing direct ownership by 28% to 60,281 units (SEC Form 4)
- CEO AND PRESIDENT Hoffman Lloyd covered exercise/tax liability with 26,765 shares and was granted 45,000 shares, increasing direct ownership by 7% to 273,750 units (SEC Form 4)
- Director Millar Donna covered exercise/tax liability with 8,029 shares, sold $35,134 worth of shares (6,971 units at $5.04) and was granted 15,000 shares (SEC Form 4)
- CFO Mcdonald Colleen J covered exercise/tax liability with 16,059 shares and was granted 27,000 shares, increasing direct ownership by 20% to 66,774 units (SEC Form 4)
- Amendment: CEO AND PRESIDENT Hoffman Lloyd was granted 50,000 shares, increasing direct ownership by 69% to 122,505 units (SEC Form 4)
Latest STE
- SEC Form 8-K filed by STERIS plc (Ireland)
- Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
- STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
- SEC Form 4 filed by STERIS plc (Ireland)
- STERIS to Present at the Morgan Stanley Healthcare Conference
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward